The global market for Epirubicin Hydrochloride Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Epirubicin Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epirubicin Hydrochloride Injection.
The Epirubicin Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Epirubicin Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epirubicin Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical
Segment by Type
5mg
10mg
Segment by Application
Leukemia
Malignant Lymphoma
Multiple Myeloma
Breast Cancer
Lung Cancer
Soft Tissue Sarcoma
Stomach Cancer
Colorectal Cancer
Ovarian Cancer
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epirubicin Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epirubicin Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Epirubicin Hydrochloride Injection Market Overview
1.1 Product Definition
1.2 Epirubicin Hydrochloride Injection by Type
1.2.1 Global Epirubicin Hydrochloride Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 5mg
1.2.3 10mg
1.3 Epirubicin Hydrochloride Injection by Application
1.3.1 Global Epirubicin Hydrochloride Injection Market Value by Application (2024 VS 2031)
1.3.2 Leukemia
1.3.3 Malignant Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Lung Cancer
1.3.7 Soft Tissue Sarcoma
1.3.8 Stomach Cancer
1.3.9 Colorectal Cancer
1.3.10 Ovarian Cancer
1.4 Global Epirubicin Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Epirubicin Hydrochloride Injection Revenue 2020-2031
1.4.2 Global Epirubicin Hydrochloride Injection Sales 2020-2031
1.4.3 Global Epirubicin Hydrochloride Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Epirubicin Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Epirubicin Hydrochloride Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Epirubicin Hydrochloride Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Epirubicin Hydrochloride Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Epirubicin Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Product Type & Application
2.7 Global Key Manufacturers of Epirubicin Hydrochloride Injection, Date of Enter into This Industry
2.8 Global Epirubicin Hydrochloride Injection Market Competitive Situation and Trends
2.8.1 Global Epirubicin Hydrochloride Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Epirubicin Hydrochloride Injection Players Market Share by Revenue
2.8.3 Global Epirubicin Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Epirubicin Hydrochloride Injection Market Scenario by Region
3.1 Global Epirubicin Hydrochloride Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Epirubicin Hydrochloride Injection Sales by Region: 2020-2031
3.2.1 Global Epirubicin Hydrochloride Injection Sales by Region: 2020-2025
3.2.2 Global Epirubicin Hydrochloride Injection Sales by Region: 2026-2031
3.3 Global Epirubicin Hydrochloride Injection Revenue by Region: 2020-2031
3.3.1 Global Epirubicin Hydrochloride Injection Revenue by Region: 2020-2025
3.3.2 Global Epirubicin Hydrochloride Injection Revenue by Region: 2026-2031
3.4 North America Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Epirubicin Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Epirubicin Hydrochloride Injection Sales by Country (2020-2031)
3.4.3 North America Epirubicin Hydrochloride Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Epirubicin Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Epirubicin Hydrochloride Injection Sales by Country (2020-2031)
3.5.3 Europe Epirubicin Hydrochloride Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epirubicin Hydrochloride Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Epirubicin Hydrochloride Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Epirubicin Hydrochloride Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Epirubicin Hydrochloride Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Epirubicin Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Epirubicin Hydrochloride Injection Sales by Country (2020-2031)
3.7.3 Latin America Epirubicin Hydrochloride Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epirubicin Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Epirubicin Hydrochloride Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Epirubicin Hydrochloride Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Epirubicin Hydrochloride Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Epirubicin Hydrochloride Injection Sales by Type (2020-2031)
4.1.1 Global Epirubicin Hydrochloride Injection Sales by Type (2020-2025)
4.1.2 Global Epirubicin Hydrochloride Injection Sales by Type (2026-2031)
4.1.3 Global Epirubicin Hydrochloride Injection Sales Market Share by Type (2020-2031)
4.2 Global Epirubicin Hydrochloride Injection Revenue by Type (2020-2031)
4.2.1 Global Epirubicin Hydrochloride Injection Revenue by Type (2020-2025)
4.2.2 Global Epirubicin Hydrochloride Injection Revenue by Type (2026-2031)
4.2.3 Global Epirubicin Hydrochloride Injection Revenue Market Share by Type (2020-2031)
4.3 Global Epirubicin Hydrochloride Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Epirubicin Hydrochloride Injection Sales by Application (2020-2031)
5.1.1 Global Epirubicin Hydrochloride Injection Sales by Application (2020-2025)
5.1.2 Global Epirubicin Hydrochloride Injection Sales by Application (2026-2031)
5.1.3 Global Epirubicin Hydrochloride Injection Sales Market Share by Application (2020-2031)
5.2 Global Epirubicin Hydrochloride Injection Revenue by Application (2020-2031)
5.2.1 Global Epirubicin Hydrochloride Injection Revenue by Application (2020-2025)
5.2.2 Global Epirubicin Hydrochloride Injection Revenue by Application (2026-2031)
5.2.3 Global Epirubicin Hydrochloride Injection Revenue Market Share by Application (2020-2031)
5.3 Global Epirubicin Hydrochloride Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Akorn
6.1.1 Akorn Company Information
6.1.2 Akorn Description and Business Overview
6.1.3 Akorn Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Akorn Epirubicin Hydrochloride Injection Product Portfolio
6.1.5 Akorn Recent Developments/Updates
6.2 Aurobindo Pharma
6.2.1 Aurobindo Pharma Company Information
6.2.2 Aurobindo Pharma Description and Business Overview
6.2.3 Aurobindo Pharma Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aurobindo Pharma Epirubicin Hydrochloride Injection Product Portfolio
6.2.5 Aurobindo Pharma Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Company Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cipla Epirubicin Hydrochloride Injection Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Ebewe Pharma
6.4.1 Ebewe Pharma Company Information
6.4.2 Ebewe Pharma Description and Business Overview
6.4.3 Ebewe Pharma Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ebewe Pharma Epirubicin Hydrochloride Injection Product Portfolio
6.4.5 Ebewe Pharma Recent Developments/Updates
6.5 Fresenius Kabi Usa
6.5.1 Fresenius Kabi Usa Company Information
6.5.2 Fresenius Kabi Usa Description and Business Overview
6.5.3 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fresenius Kabi Usa Epirubicin Hydrochloride Injection Product Portfolio
6.5.5 Fresenius Kabi Usa Recent Developments/Updates
6.6 Impax Laboratories
6.6.1 Impax Laboratories Company Information
6.6.2 Impax Laboratories Description and Business Overview
6.6.3 Impax Laboratories Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Impax Laboratories Epirubicin Hydrochloride Injection Product Portfolio
6.6.5 Impax Laboratories Recent Developments/Updates
6.7 Mylan Laboratories
6.7.1 Mylan Laboratories Company Information
6.7.2 Mylan Laboratories Description and Business Overview
6.7.3 Mylan Laboratories Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Laboratories Epirubicin Hydrochloride Injection Product Portfolio
6.7.5 Mylan Laboratories Recent Developments/Updates
6.8 Nippon Kayaku
6.8.1 Nippon Kayaku Company Information
6.8.2 Nippon Kayaku Description and Business Overview
6.8.3 Nippon Kayaku Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nippon Kayaku Epirubicin Hydrochloride Injection Product Portfolio
6.8.5 Nippon Kayaku Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Epirubicin Hydrochloride Injection Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Sawai Pharmaceutical
6.10.1 Sawai Pharmaceutical Company Information
6.10.2 Sawai Pharmaceutical Description and Business Overview
6.10.3 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sawai Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.10.5 Sawai Pharmaceutical Recent Developments/Updates
6.11 Zennova
6.11.1 Zennova Company Information
6.11.2 Zennova Description and Business Overview
6.11.3 Zennova Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zennova Epirubicin Hydrochloride Injection Product Portfolio
6.11.5 Zennova Recent Developments/Updates
6.12 Beijing Union Pharmaceutical Factory
6.12.1 Beijing Union Pharmaceutical Factory Company Information
6.12.2 Beijing Union Pharmaceutical Factory Description and Business Overview
6.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Injection Product Portfolio
6.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.13 Hisun Pharmaceutical
6.13.1 Hisun Pharmaceutical Company Information
6.13.2 Hisun Pharmaceutical Description and Business Overview
6.13.3 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hisun Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.13.5 Hisun Pharmaceutical Recent Developments/Updates
6.14 Hanhui Pharmaceutical
6.14.1 Hanhui Pharmaceutical Company Information
6.14.2 Hanhui Pharmaceutical Description and Business Overview
6.14.3 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hanhui Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.14.5 Hanhui Pharmaceutical Recent Developments/Updates
6.15 Lunan Pharmaceutical
6.15.1 Lunan Pharmaceutical Company Information
6.15.2 Lunan Pharmaceutical Description and Business Overview
6.15.3 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Lunan Pharmaceutical Epirubicin Hydrochloride Injection Product Portfolio
6.15.5 Lunan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epirubicin Hydrochloride Injection Industry Chain Analysis
7.2 Epirubicin Hydrochloride Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epirubicin Hydrochloride Injection Production Mode & Process Analysis
7.4 Epirubicin Hydrochloride Injection Sales and Marketing
7.4.1 Epirubicin Hydrochloride Injection Sales Channels
7.4.2 Epirubicin Hydrochloride Injection Distributors
7.5 Epirubicin Hydrochloride Injection Customer Analysis
8 Epirubicin Hydrochloride Injection Market Dynamics
8.1 Epirubicin Hydrochloride Injection Industry Trends
8.2 Epirubicin Hydrochloride Injection Market Drivers
8.3 Epirubicin Hydrochloride Injection Market Challenges
8.4 Epirubicin Hydrochloride Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical
听
听
*If Applicable.